Mainly, IGF2BP3 was highly expressed in diverse tumor types, such as GBMLGG, glioblastoma multiforme (GBM), LGG, lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), PAAD, head and neck squamous cell carcinoma (HNSC), uterine corpus endometrial carcinoma (UCEC), colon adenocarcinoma (COAD), and esophageal carcinoma (ESCA). Here, IGF2BP3 is linked to squamous cell lung carcinoma.